CLINICAL_TRIALS
trial_result
· 2013-10-29
Clinical Trial Update: Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder [Phase 3]
Summary
Phase 3 results assess safety and efficacy of Levomilnacipran ER in adults with Major Depressive Disorder; the study results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-10-29